Chapter 109

1. Definition. The ductus arteriosus is a large vessel that connects the main pulmonary trunk (or proximal left pulmonary artery) with the descending aorta, some 5–10 mm distal to the origin of the left subclavian artery. In the fetus, it serves to shunt blood away from the lungs and is essential (closure in utero may lead to fetal demise or pulmonary hypertension). In full-term healthy newborns, functional closure of the ductus occurs rapidly after birth. Final functional closure occurs in almost half of full-term infants by 24 h of age, in 90% by 48 h, and in all by 96 h after birth. Patent ductus arteriosus (PDA) refers to the failure of the closure process and continued patency of this fetal channel.

2. Incidence. The incidence varies according to means of diagnosis (eg, clinical signs vs echocardiography).

1. Factors associated with increased incidence of PDA:

1. Prematurity. The incidence is inversely related to gestational age. PDA is found in ~45% of infants <1750 g; in infants weighing <1000 g, the incidence is closer to 80%.

1. Respiratory distress syndrome (RDS) and surfactant treatment. The presence of RDS is associated with an increased incidence of a PDA, and this is correlated with the severity of RDS. After surfactant treatment, there is an increased risk of a clinically symptomatic PDA; moreover, surfactant may lead to an earlier clinical presentation of a PDA.

1. Fluid administration. An increased intravenous fluid load in the first few days of life is associated with an increased incidence of PDA.

1. Asphyxia.

1. Congenital syndromes. PDA is present in 60–70% of infants with congenital rubella syndrome. Trisomy 13, trisomy 18, Rubinstein-Taybi syndrome, and XXXXX (Penta X) syndrome are associated with an increased incidence of PDA.

1. High altitude. Infants born at a high altitude have an increased incidence of PDA.

1. Congenital heart disease. A PDA may occur as part of a congenital heart disease (eg, coarctation, pulmonary atresia with intact septum, transposition of the great vessels, or total anomalous pulmonary venous return).

1. Factors associated with a decreased incidence of PDA:

1. Intrauterine growth restriction (IUGR).

1. Prolonged rupture of membranes.

3. Pathophysiology. In the fetus, the ductus is essential to divert blood flow from the high-resistance pulmonary circulation to the descending aorta. After birth, functional closure of the ductus occurs within hours (but up to 3–4 days). Complete anatomic closure with fibrosis and permanent sealing of the lumen takes up to 2–3 weeks. An increase in PaO2, as occurs with ventilation after birth, constricts the ductus in mature animals. Other factors, such as the release of vasoactive substances (eg, acetylcholine), may contribute to the postnatal closure of the ductus under physiologic conditions. Of paramount importance, however, is the dilatory effects of prostaglandins (E1 and E2) and prostacyclin on the ductus. Inhibitors of prostaglandin synthesis produce constriction of the ductus. Thus the patency or closure of the ductus depends on the balance between the various constricting effects (eg, of oxygen) and the relaxing effects of various prostaglandins. The effects of oxygen and prostaglandins vary at different gestational ages. Oxygen has less ...

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

## Subscription Options

### AccessPediatrics Full Site: One-Year Subscription

Connect to the full suite of AccessPediatrics content and resources including 20+ textbooks such as Rudolph’s Pediatrics and The Pediatric Practice series, high-quality procedural videos, images, and animations, interactive board review, an integrated pediatric drug database, and more.